Allianz Asset Management
AVNR

Allianz Asset Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Allianz Asset Management’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-311,463
Closed -$5.28M – 2474
2014
Q4 		$5.28M Sell
311,463
-29,283
-9% -$412K 0.01% 1197
2014
Q3 		$4.06M Sell
340,746
-16,776
-5% -$115K ﹤0.01% 1162
2014
Q2 		$2.02M Sell
357,522
-2,008
-0.6% -$9.25K ﹤0.01% 1206
2014
Q1 		$1.32M Sell
359,530
-21,755
-6% -$82.9K ﹤0.01% 1329
2013
Q4 		$1.28M Sell
381,285
-838,019
-69% -$3.46M ﹤0.01% 1334
2013
Q3 		$5.17M Buy
1,219,304
+502,204
+70% +$2.38M 0.01% 910
2013
Q2 		$3.3M Buy
+717,100
New +$2.46M ﹤0.01% 1038

Allianz Asset Management's AVNR Position: Q1 2015 in Review

Allianz Asset Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 311,463 shares — an estimated $5.28M sold.

Allianz Asset Management first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $5.28M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Allianz Asset Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Allianz Asset Management sold 311,463 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $5.28M.
  • Allianz Asset Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Allianz Asset Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $5.28M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Allianz Asset Management's 13F filing for Q1 2015, filed 15 May 2015.